Innovative antibody for

personalized medicine

"Skolkovo" residentship

August, 18, 2011, TheraMAB LLC. earned the resident status at the business and innovation center of “Skolkovo” Fund at the inauguration ceremony in Gorky Central Park of Culture and Leisure.

The innovation project was highly appreciated by “Skolkovo” Fund experts represented by lead foreign and Russian scientists, technologic businessmen and venture investors."Skolkovo" resident status gives its new owners new ample opportunities and provides a number of benefits, such as tax incentives for up to 10 years: income tax remission, insurance and custom privileges and access to government services and grants of up to 300 million rubles.

In his speech, Director General of TheraMAB LLC., Dmitry Tyrsin stressed the importance of close cooperation between “Skolkovo” Fund and innovation start-up projects aimed at creating original drugs and expressed his hope on further effective cooperation with the Fund in this direction.